Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Zincum isovalerianicum is a homeopathic and anthroposophic preparation consisting of the zinc salt of isovaleric acid. It is typically synthesized from zinc oxide and isovaleric acid in ethanol, resulting in small white crystals with a characteristic valerian-like odor. In homeopathic medicine, it is primarily indicated for conditions involving nervous system excitability and exhaustion, including sleep disorders, restless legs syndrome, various forms of neuralgia (nerve pain), and anxiety. As a homeopathic remedy, it is available in various potencies (dilutions) and is marketed in several dosage forms such as globules (pellets), oral drops, and injectable solutions. It is produced by multiple specialized manufacturers of homeopathic and anthroposophic medicines, including Weleda, Hevert-Arzneimittel, and DHU-Arzneimittel.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on zincum isovalerianicum.